Oren Elmaliah
CIK: 0001713701
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 15, 2025MYSZ
My Size, Inc.
Award(A)Direct30K shares- - Jun 4, 2025MYSZ
My Size, Inc.
Disposition(D)DirectOption to purchase Common Stock (right to buy)
150 shares- - Jun 4, 2025MYSZ
My Size, Inc.
Award(A)DirectOption to purchase Common Stock (right to buy)
150 shares-
1-3 of 3 transactions
About Elmaliah Oren
Elmaliah Oren (SEC CIK 0001713701) files insider reports with the SEC as Interim CFO of Nasus Pharma Ltd (NSRX) and Chief Financial Officer of My Size, Inc. (MYSZ).
Signal8 holds 3 ownership filings by Elmaliah Oren (1 Form 3, 2 Form 4), filed between Jun 6, 2025 and Sep 23, 2026. Those filings report 3 transactions, from Jun 4, 2025 to Dec 15, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Elmaliah Oren's filings is in TEL-AVIV-YAFO.
Recent filings by Elmaliah Oren
Other insiders filing for Nasus Pharma Ltd (NSRX)
- Rubin Eyal, Chief Financial Officer
- Teleman Dan Benjamin, Chief Executive Officer
- Silberman David, Director
- Shacham Sharon, Director
- Gilboa Udi, Officer
- Hershman Ronnie, Director